7A7 MAb: a new tool for the pre-clinical evaluation of EGFR-based therapies.
about
Pharmacokinetics and Biodistribution Study of 7A7 Anti-Mouse Epidermal Growth Factor Receptor Monoclonal Antibody and Its F(ab')(2) Fragment in an Immunocompetent Mouse ModelFrequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it's potential therapeutic implications.Lonely killers: effector cell- and complement-independent non-proapoptotic cytotoxic antibodies inducing membrane lesions.Active antimetastatic immunotherapy in Lewis lung carcinoma with self EGFR extracellular domain protein in VSSP adjuvant.Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis.Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.Characterization of 7A7, an anti-mouse EGFR monoclonal antibody proposed to be the mouse equivalent of cetuximab.Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3.Trial watch: Chemotherapy with immunogenic cell death inducers.Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis
P2860
Q36440219-968DF3C2-5579-4881-826A-DF7F8D150F67Q37280403-C4E66EB6-37DF-4F7F-A1D3-5292FFC3AF1EQ37962075-5FA41964-A1F2-43FB-A11C-2B5A18C0AD96Q40255826-7E8B5BE0-1F0B-4417-8DA4-01DE1C912167Q41989317-3FB3194F-8B62-4BAF-9E1B-90231C5A0F0AQ47704805-F38261A9-7465-40C7-9793-A6FA7AE5F27EQ52649596-4AACC948-EF94-41E9-BFB3-36E036A1F50AQ55439726-D89E7129-0F94-4A30-B8C1-65FC256DB8DBQ55658029-CE05B99A-05E1-4156-87C4-D17AB2A28F90Q58699533-3ADEE325-91CE-4304-A84B-EAE787B8F90F
P2860
7A7 MAb: a new tool for the pre-clinical evaluation of EGFR-based therapies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
7A7 MAb: a new tool for the pre-clinical evaluation of EGFR-based therapies.
@en
type
label
7A7 MAb: a new tool for the pre-clinical evaluation of EGFR-based therapies.
@en
prefLabel
7A7 MAb: a new tool for the pre-clinical evaluation of EGFR-based therapies.
@en
P2093
P356
P1433
P1476
7A7 MAb: a new tool for the pre-clinical evaluation of EGFR-based therapies
@en
P2093
Belinda Sanchez
Greta Garrido
Hilda Maria Rodriguez
Luis Enrique Fernandez
Pablo Lorenzano
P304
P356
10.1089/1536859041224280
P577
2004-06-01T00:00:00Z